KMT2A and neoplasm: For the methylation diversity and mutation differentiation, there are still several genes (such as TCF3, MLL, MEN1, SHH, CTNNB1 and FZD1, listed in Table 3) that have been reported to participate in the tumor associated pathways (The detailed analysis of the important candidates can be seen in Supplementary Material V).